Clinical Evaluation Of Ventricular Septal Defect (VSD) In Children at Sohag Univesity Hospital

ConditionVentricular Septal Defect

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-16

SponsorSohag University

About this trial

ventricular septal defect(VSD) are one of the most common significant CHD and account for up to 40% of all cardiac abnormalities.VSD is commonly isolated defect as well as intrinsic component of several complex cardiac malformations including tetrology of fallot ,double- outlet right ventricle(RV),transposition of great vessles,aortic coartication or interruption ,and truncus arteriosus

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

all children from date of birth to age of 16 years old including both genders diagnosed to have isolated VSD or apart from another cardiac anomalies

Disqualifiers

None

Trial population

all children from date of birth to age of 16 years old including both genders diagnosed to have isolated VSD or apart from another cardiac anomalies

Trial design

Design model

Case-only

Time perspective

Cross-sectional

Treatments tested in this trial

ECHO
Device
type and size of ventricular septal defect

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

size of VSD

size of VSD in mm according echocardiology

Time frame

12 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

Apply now